A new technical brief published today by the World Health Organization (WHO), Improving the Lives of People with Epilepsy, sets out the actions required to deliver an integrated approach to epilepsy…
Details
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six company-sponsored Epidiolex® (cannabidiol) oral solution presentations, including three late-breaking abstracts, will be shared at the upcoming 2022 American Epilepsy Society (AES) annual meeting, which will…
Details
Justin Fields regained consciousness in the back of the ambulance with no recollection of what had happened. All he remembered from that morning in ninth grade was feeling “a little bit…
Details
Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. On the Mayo Clinic Q&A podcast,…
Details
The location and characteristics of an epilepsy center in the United States could affect the types of presurgical testing given to patients with drug-resistant epilepsy, according to study findings published in Epilepsia. This…
Details
Epilepsy is a chronic disorder in which brain cells produce abnormal electrical signals in the brain, causing repeated seizures (via Cleveland Clinic). It’s one of the most common neurological disorders worldwide,…
Details
Cannabinoids have been shown to effectively control seizures across the epilepsy spectrum; however, quality control of products remains a challenge, according to a presenter at BRAINWeek 2022. Read the full…
Details
In the mammalian brain, the chief inhibitory neurotransmitter is called GABA. The gene SLC6A1 encodes the GABA transporter GAT1, and in Neurobiology of Disease, Felicia Mermer, Sarah Poliquin, Jing-Qiong Kang, MD, PhD, and colleagues report experiments…
Details
Epilepsy is an unpredictable and often misunderstood disease. When the condition isn’t controlled, seizures can happen at any time and disrupt your life, relationships and wellbeing. Neurologists and neurosurgeons at…
Details